Health In Tech, Inc.

NASDAQ:HIT

Software - Application

Technology
$0.93 +0.00%

+$0.00 today

Market cap
$50.13M
Beta
2.94
P/E (TTM)
-75.2
EPS (TTM)
-$0.01
52W Low $0.59High $4.02

Volume 0.04M

Average 0.23M

HIT Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Health In Tech, Inc.NASDAQ: HIT

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables declines year over year

Q1 FY2026 accounts receivables of $2.99M (cash outflow) fell 24.3% year over year, ahead of the -44.1% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +50.4% a year.

Context

  • Accounts receivables amounted to 7.3% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -24.3% holds above the trailing-twelve-month pace of -44.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.99M-2016.4% QoQ
Last fiscal yearDec 2025
-$2.44M-237.9% YoY
LTMMar 2026
-$1.48M-44.1% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-24.3%——
1 year-237.9%——
3-year CAGR+50.4%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(2.44M) USD
Year-over-year change
-237.9%

Accounts Receivables vs competitors

How HIT compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -44.1% is the 5th highest of 8, against a peer median of -19.1%.
  • Accounts receivables amounts to 4.3% of revenue for HIT, versus a peer median of 4.2%.
HIT Competitors
Accounts Receivables for HIT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LAWRRobot Consulting Co., Ltd. ADSFY2025¥79.36M JPY+920.6%+145.6%11.7%
TEADTeads Holding Co.LTM Mar 2026$46.94M USD+8.9%+69.9%3.7%
DSPViant Technology Inc.LTM Mar 2026$15.38M USD-19.1%—4.2%
TROOTROOPS, Inc.FY2025$6.4M USD+219.4%+828.4%37.4%
SVCOSilvaco Group, Inc. Common StockLTM Mar 2026$3.73M USD-45.0%-53.6%5.6%
STEMStem, Inc.LTM Mar 2026$1.61M USD-101.7%—1.1%
HITHealth In Tech, Inc.LTM Mar 2026$1.48M USD-44.1%+50.4%4.3%
EXFYExpensify, Inc.LTM Mar 2026$436K USD-170.6%-35.8%0.3%
Peer median (excluding HIT) —-19.1%+69.9%4.2%

Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(243.34K)3.96M670.48K1.28M
Depreciation & Amortization0339.3K541.14K900.58K
Deferred Income Tax9K133.98K(93.3K)429K
Stock-Based Compensation566.04K0468.49K1.57M
Change in Working Capital451.06K(2.89M)156.52K(5.23M)
Accounts Receivables(716K)(2.94M)1.77M(2.44M)
Inventory0000
Accounts Payables449.95K2.15M(851.96K)2.36M
Other Working Capital717.1K(2.09M)(759.05K)(5.15M)
Other Non-Cash Items0(16K)432.88K4.19M
Operating Cash Flow782.75K1.53M2.18M3.13M
Capital Expenditures(1.22M)(1.14M)(900.76K)(3.19M)
Acquisitions (Net)0000
Purchases of Investments0000
Sales of Investments0000
Other Investing Activities0(800K)64K64K
Investing Cash Flow(1.22M)(1.94M)(836.76K)(3.13M)
Debt Repayment(74.09K)1.65M(2.15M)0
Common Stock Issued008.21M23.43K
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities(46.97K)(306.12K)(1.98M)(210.82K)
Financing Cash Flow1.88M1.34M4.09M(187.39K)
Effect of Forex Changes0000
Net Change in Cash1.44M928.4K5.43M(179.49K)
Free Cash Flow(436.63K)384.52K1.28M(56.11K)

Health In Tech, Inc.

NASDAQ:HIT

Intrinsic Alpha fair value

Locked

Current Price

$0.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.